October 13, 2016
STENTYS sees revenue up 26%over the first 9 months
STENTYS a medical technology company today announced its revenue for the third quarter and first 9 months to September 30, 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: STENTYS